Nan Li

Nan Li has extensive work experience in the venture capital and investment industry. Starting in 2018, Nan Li became an Investor at Dyno Therapeutics. In 2019, Nan Li expanded their investment portfolio by becoming an Investor at Octave, Inato, LabGenius, and n8n.io, as well as serving as an Investor and Board Director at Inato and LabGenius. In 2020, Nan Li continued their involvement in the investment sector, taking on roles as an Investor and Board Observer at Anagenex and Swiftscale Biologics. In 2021, Nan Li became an Investor and Board Director at Iterative Scopes. Most recently, in 2022, Nan Li embarked on a new venture by founding Dimension and assuming the role of Founder & Managing Partner. Prior to this, from 2015 to 2022, Nan Li held the positions of Venture Partner and Managing Director at Obvious Ventures. The roles and experiences of Nan Li have been consistently focused on investment, board advisory, and leadership in various companies.

Nan Li holds a Bachelor of Science in Computer Science from the University of Michigan. However, no specific information is available regarding the start and end year of this education.